AKT1 and cancer: Magnolol is known to inhibit various molecular signaling pathways as described in previous studies.15 Of these, the MAPK‐ERK and PI3K/Akt pathways are usually activated in cancer cells to promote cell survival.16 Hence, the effect of magnolol on these molecular signaling pathways was investigated.